Lunit Unveils Enhanced AI-Powered CXR Software Update
The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
The newly launched artificial intelligence (AI) software update Lunit Insight CXR4 may provide an array of pertinent features to facilitate smoother chest X-ray (CXR) reading for radiologists with high volume worklists.
In addition to identifying a variety of chest abnormalities, the Insight CXR4 software now provides adjunctive detection of acute bone fractures, according to Lunit, the manufacturer of the software.
For radiologists in high-volume settings, the AI-enabled Lunit Insight CXR4 software update offers current-prior CXR comparison and a 99.5 percent negative predictive value (NPV) for normal CXRs, features that facilitate smoother workflow. (Image courtesy of Lunit.)
The company said the Lunit Insight CXR4 also offers comparison of current and prior CXRs, including nodule comparisons. Another key attribute of Lunit Insight CXR4 involves the flagging of normal cases. Lunit said the software, which was trained on over 1.2 million CXRs, provides a 99.5 percent negative predictive value (NPV) and generates automated reporting of normal cases.
“With Lunit Insight CXR4, we’ve gone beyond expanding detection —we’ve focused on what truly helps clinicians in their day-to-day workflow,” said Brandon Suh, the CEO of Lunit. “Features like active normal flagging and current-prior comparison are designed to reduce reading time and improve triage confidence, especially in high-volume settings.”
Lunit has achieved CE MDR certification for Lunit Insight CXR4 in Europe. As this article went to press, the software update had not been submitted for FDA 510(k) clearance, according to Lunit.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
